RPMI-8866 人 B 淋巴母细胞系 / BioVector® RPMI-8866 Human B Lymphoblastoid Cell Line
- 价 格:¥99850
- 货 号:BioVector® RPMI-8866
- 产 地:北京
- BioVector NTCC典型培养物保藏中心
- 联系人:Dr.Xu, Biovector NTCC Inc.
电话:400-800-2947 工作微信:1843439339 (QQ同号)
邮件:Biovector@163.com
手机:18901268599
地址:北京
- 已注册
BioVector® RPMI-8866 人 B 淋巴母细胞系 / BioVector® RPMI-8866 Human B Lymphoblastoid Cell Line
通用定义 / General Definition:BioVector® RPMI-8866 是一种源自人类外周血的内源性 EB 病毒 (EBV) 转化的 B 淋巴母细胞系。该细胞系最初建立于 20 世纪 60 年代(来自一名患有慢性髓细胞白血病的患者),但由于其成熟的 B 细胞特征,它被广泛用作免疫学研究的标准模型。RPMI-8866 细胞稳定表达多种细胞表面标志物,包括 CD23 和 MHC II 类分子,使其成为研究 B 细胞激活、抗原呈递、免疫球蛋白合成以及细胞因子调控的理想工具。
BioVector® RPMI-8866 is a human B lymphoblastoid cell line derived from peripheral blood and transformed by endogenous Epstein-Barr Virus (EBV). Originally established in the 1960s (from a patient with chronic myelogenous leukemia), it has since become a standard model in immunology due to its mature B-cell characteristics. RPMI-8866 cells constitutively express various surface markers, including CD23 and MHC class II molecules, making them an ideal tool for studying B-cell activation, antigen presentation, immunoglobulin synthesis, and cytokine regulation.
BioVector® RPMI-8866 技术说明书 (Technical Datasheet)
中文版说明书 (Chinese Datasheet)
1. 产品基本信息
产品名称: BioVector® RPMI-8866 人 B 淋巴母细胞
组织来源: 外周血 (Peripheral Blood)
生长特性: 悬浮生长 (Suspension)
细胞形态: 淋巴母细胞样,通常呈圆形,单个或成簇悬浮。
2. 培养条件
基础培养基: BioVector® RPMI-1640 培养基
血清添加: 10% - 15% BioVector® 优质胎牛血清 (FBS)
培养环境: 37 摄氏度,5% CO2
传代与维护: 细胞密度应维持在 $2 \times 10^5$ 至 $1 \times 10^6$ cells/mL 之间。传代时只需通过离心或稀释方式补充新鲜培养基,无需消化处理。
3. 细胞应用
免疫学研究: 研究 CD23(低亲和力 IgE 受体)的表达及其在过敏反应中的作用。
细胞因子分析: 评估 IL-4、IL-13 等细胞因子对 B 细胞功能的调节。
EBV 病毒研究: 作为 EB 病毒永生化 B 细胞的模型,研究病毒潜伏感染机制。
4. 注意事项
结团现象: RPMI-8866 细胞在生长良好时倾向于形成明显的细胞团簇,这属于正常生理状态,通常通过轻轻吹打即可分散。
安全性: 由于该细胞系含有内源性 EB 病毒,必须在生物安全二级 (BSL-2) 环境下操作。
English Datasheet
1. General Product Information
Product Name: BioVector® RPMI-8866 Human B Lymphoblastoid Cell Line
Tissue Source: Peripheral Blood
Growth Properties: Suspension
Morphology: Lymphoblast-like; typically round cells growing individually or in clusters.
2. Culture Conditions
Basal Medium: BioVector® RPMI-1640 Medium
Serum Supplement: 10% - 15% BioVector® Fetal Bovine Serum (FBS)
Incubation: 37 degrees Celsius, 5% CO2
Maintenance: Maintain cell density between $2 \times 10^5$ and $1 \times 10^6$ cells/mL. Subculture by dilution or centrifugation with fresh medium; no trypsinization is required for suspension cells.
3. Applications
Immunology Research: Studying the expression of CD23 (the low-affinity IgE receptor) and its role in allergic responses.
Cytokine Signaling: Evaluating the modulation of B-cell functions by cytokines such as IL-4 and IL-13.
EBV Pathogenesis: Serving as a model for EBV-immortalized B cells to investigate viral latency and oncogenesis.
4. Key Usage Notes
Cell Clumping: It is characteristic for healthy RPMI-8866 cells to form clusters in suspension. These aggregates can be gently dissociated by pipetting during subculturing.
Safety Protocols: As the cell line harbors endogenous Epstein-Barr Virus, it must be handled under Biosafety Level 2 (BSL-2) guidelines.
注意 / Note: BioVector® 建议定期检查培养物的细胞密度,避免过度汇合导致营养耗竭。为确保实验的科学性,建议定期进行支原体检测。
BioVector® recommends regular monitoring of cell density to prevent nutrient depletion from overgrowth. Periodic mycoplasma screening is highly advised to ensure the integrity of your research.

BioVector NTCC质粒载体菌株细胞蛋白抗体基因保藏中心
E-mail: BioVector@163.com
http://www.biovector.net
- 公告/新闻




